-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 MJA8Tu/a7rcMtVFuFMElAfLHjNbvUsY6oBIPgOlGgdRQY1gUbCbu8NTI3P455uk6
 N70kescn0/P6w/80vDf5hQ==

<SEC-DOCUMENT>0000012208-07-000014.txt : 20070503
<SEC-HEADER>0000012208-07-000014.hdr.sgml : 20070503
<ACCEPTANCE-DATETIME>20070503165852
ACCESSION NUMBER:		0000012208-07-000014
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20070331
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20070503
DATE AS OF CHANGE:		20070503

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO RAD LABORATORIES INC
		CENTRAL INDEX KEY:			0000012208
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				941381833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07928
		FILM NUMBER:		07816278

	BUSINESS ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DR
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547
		BUSINESS PHONE:		5107247000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k1q3312007cover.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>UNITED STATES</TITLE>
<META NAME="author" CONTENT="Tom Brida">
<META NAME="date" CONTENT="04/18/2007">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:720px"><P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>UNITED STATES</B></P>
<P style="margin:0px" align=center><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="margin:0px" align=center><B>Washington, D.C. 20549</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="line-height:21.333px; margin:0px; font-size:18.667px" align=center><B>FORM 8-K</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="margin:0px" align=center><B>CURRENT REPORT</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>Date of Report: May 3, 2007</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Date of earliest event reported)</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="line-height:12px; margin:0px"><BR></P>
<P style="line-height:10.667px; margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:18.667px" align=center><B>BIO-RAD LABORATORIES, INC.</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Exact name of registrant as specified in its charter)</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="line-height:12px; margin:0px"><BR></P>
<P style="margin:0px" align=center><B>Commission File Number: 1-7928</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=360></TD><TD width=7.133></TD><TD width=352.8></TD></TR>
<TR><TD width=360><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD width=352.8><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=360><P style="margin:0px" align=center><B>Delaware</B></P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=top width=352.8><P style="margin:0px" align=center><B>94-1381833</B></P>
</TD></TR>
<TR><TD valign=top width=360><P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(State or other jurisdiction of</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>incorporation or organization)</B></P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=top width=352.8><P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(I.R.S. Employer</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>Identification No.)</B></P>
</TD></TR>
</TABLE>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="line-height:10.667px; margin:0px; font-size:10.667px">&nbsp;</P>
<P style="margin:0px" align=center><B>1000 Alfred Nobel Dr.</B></P>
<P style="margin:0px" align=center><B>Hercules, California 94547</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Address of principal executive offices, including zip code)</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<P style="margin:0px" align=center><B>(510) 724-7000</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Registrant&#146;s telephone number, including area code)</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="line-height:10.667px; margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=562.733></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=562.733><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=565.6></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=565.6><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=616.267></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=616.267><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=615></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=615><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><B>&nbsp;</B></P>
<P style="margin:0px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=83.333></TD><TD width=285.933></TD></TR>
<TR><TD valign=top width=83.333><P style="margin:0px" align=justify><B>ITEM 2.02</B></P>
</TD><TD valign=top width=285.933><P style="margin:0px"><B>Results of Operations and Financial Condition</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px">On May 3, 2007, Bio-Rad Laboratories, Inc. announced its results of operations and financial condition as of and for the quarter ended March 31, 2007. &nbsp;A copy of the press release is furnished as Exhibit 99.1 to this report.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed to be &#147;filed&#148; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. </P>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=83.333></TD><TD width=492.667></TD></TR>
<TR><TD valign=top width=83.333><P style="margin:0px"><B>ITEM 9.01</B></P>
</TD><TD valign=top width=492.667><P style="margin:0px"><B>Financial Statements and Exhibits</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=60></TD><TD width=24></TD><TD width=497.533></TD></TR>
<TR><TD width=60><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=24><P style="margin:0px">&nbsp;</P>
</TD><TD width=497.533><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=60><P style="margin:0px"><B>Exhibit</B></P>
<P style="margin:0px"><B>Number&nbsp;</B></P>
</TD><TD valign=bottom width=24><P style="margin:0px">&nbsp;</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=497.533><P style="margin:0px"><BR></P>
<P style="margin:0px"><B>Description</B></P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin-top:2.2px; margin-bottom:0px" align=right>99.1&nbsp;</P>
</TD><TD valign=bottom width=24><P style="margin-top:2.2px; margin-bottom:0px">&nbsp;</P>
</TD><TD valign=bottom width=497.533><P style="margin-top:2.2px; margin-bottom:0px">Press release of Bio-Rad Laboratories, Inc. dated May 3, 2007</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="margin:0px; page-break-before:always" align=center><B>SIGNATURES</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin:0px">&nbsp;&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=50.867></TD><TD width=136.333></TD><TD width=29.467></TD><TD width=29.467></TD><TD width=4></TD><TD width=185.667></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=189.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=189.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=219.133 colspan=3><P style="margin:0px">BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=189.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="margin:0px">Date:</P>
</TD><TD style="border-bottom:1px solid #000000" width=136.333><P style="margin:0px">May 3, 2007</P>
</TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="margin:0px">By:</P>
</TD><TD valign=bottom width=189.667 colspan=2><P style="margin:0px">&nbsp;<U>/s/ Christine A. Tsingos</U></P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=185.667><P style="margin:0px">Christine A. Tsingos<U> </U></P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=185.667><P style="margin:0px">Vice President,</P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="margin:0px">&nbsp;</P>
</TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=4><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=185.667><P style="margin:0px">Chief Financial Officer</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<A NAME="id_11"></A><A NAME="id_12"></A><P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>EXHIBIT INDEX</B></P>
<P style="margin:0px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=34.2></TD><TD width=28.267></TD><TD width=513.533></TD></TR>
<TR><TD width=34.2><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=28.267><P style="margin:0px">&nbsp;</P>
</TD><TD width=513.533><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=34.2><P style="line-height:12px; margin:0px; font-size:9.333px"><B>Exhibit</B></P>
<P style="line-height:12px; margin:0px; font-size:9.333px"><B>Number</B></P>
</TD><TD valign=bottom width=28.267><P style="margin:0px; font-size:9.333px">&nbsp;</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=513.533><P style="line-height:12px; margin:0px; font-size:9.333px"><B>Description</B></P>
</TD></TR>
<TR><TD valign=top width=34.2><P style="margin:0px">99.1</P>
</TD><TD valign=bottom width=28.267><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=513.533><P style="margin:0px">Press release of Bio-Rad Laboratories, Inc. dated May 3, 2007</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1 CHARTER
<SEQUENCE>2
<FILENAME>ex991033107.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Exhibit 99</TITLE>
<META NAME="author" CONTENT="Stephanie Trudrung">
<META NAME="date" CONTENT="05/03/2007">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:643.2px"><P style="line-height:22.667px; margin:0px; font-family:Arial" align=right><FONT FACE="Arial"><B><U>Exhibit 99.1</U></B></FONT></P>
<P style="margin:0px" align=right><BR></P>
<P style="margin:0px; padding-right:43.2px; font-family:Arial"><B>FOR IMMEDIATE RELEASE</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px; font-family:Arial" align=center><B>BIO-RAD REPORTS FIRST-QUARTER 2007 FINANCIAL RESULTS</B></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:Arial"><B>HERCULES, CA &#150; May 3, 2007</B> &#150; Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced financial results today for the first quarter year ended March 31, 2007. <FONT COLOR=#0000FF>&nbsp;</FONT></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">The Company posted revenues of $322.5 million, up 4.6% compared to $308.3 million reported for the first quarter of 2006<FONT COLOR=#0000FF>. </FONT>On a currency-neutral basis, revenues increased<FONT COLOR=#0000FF> </FONT>0.4% compared to the same period last year.<FONT COLOR=#0000FF> </FONT>Net income for the first quarter was $27.0 million compared to $31.2 million reported for the same quarter in 2006.<FONT COLOR=#0000FF> </FONT>First-quarter net income was<FONT COLOR=#0000FF> </FONT>$1.02 per share, or $0.99 per share on a fully diluted basis, compared to<FONT COLOR=#0000FF> </FONT>$1.19 and $1.16, respectively, during the first quarter last year. First-quarter gross margin from operations was 55.6% compared to 56.9% in the same period last year.<FONT COLOR=#0000FF> </FONT></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">&#147;While sales were solid in our Clinical Diagnostics segment, our Life Science segment continues to face some slowness in the US and Asian academic segments,&#148; said<FONT COLOR=#FF0000> </FONT>Norman Schwartz, Bio-Rad President and Chief Executive Officer. &#147;We are encouraged, however, by growth across several product lines and the introduction of new products like the Mini-PROTEAN<SUP>&#174;</SUP> Tetra cell and the Profinia<SUP>&#8482;</SUP> protein purification system.&#8221;</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:22.667px; margin:0px; font-family:Arial"><B>Life Science </B></P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">Life Science segment net sales for the quarter were $141.6 million, down 2.2% compared to the same period last year. On a currency-neutral basis, segment sales decreased by 5.7%. Overall performance in this segment continued to be impacted by the drop in BSE (bovine spongiform encephalopathy) testing revenues as both the number of animals tested and the average selling price continues to decline. In addition, reduced government sponsored research funding has impacted sales across the segment's traditional product lines. This weakness was somewhat offset, however, by the introduction of the ProteOn<SUP>&#8482;</SUP> XPR36 protein interaction array system and growth of the Bio-Plex<SUP>&#174;</SUP> suspension array system instrument and reagents. Sales of the Bio-Plex system were driven in part by 57 new assays that were introduced in 2006. During the quarter, the segment introduced a number of new products including the Mini-PROTEAN Tetra cell, th
e Company&#146;s fourth generation electrophoresis system; as well as the Profinia protein purification system. </P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:22.667px; margin:0px; font-family:Arial"><B>Clinical Diagnostics</B></P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">The Clinical Diagnostics segment reported net sales of<FONT COLOR=#0000FF> </FONT>$177.6 million for the quarter, up<FONT COLOR=#0000FF> </FONT>10.8%<FONT COLOR=#0000FF> </FONT></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; padding-right:43.2px; font-family:Arial" align=center><B>(more)</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="line-height:22.667px; margin:0px; padding-right:43.2px; font-family:Arial"><B>Bio-Rad Reports First-Quarter 2007 Financial Results</B></P>
<P style="margin:0px; font-family:Arial"><B>Page 2</B></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">compared to the first quarter last year,<FONT COLOR=#0000FF> </FONT>or 5.9% excluding currency effects.<FONT COLOR=#0000FF> </FONT>These results were largely due to continued growth across all product lines, most notably blood virus and quality control products. &nbsp;&nbsp;Strong blood virus sales in the US were in part the result of customers converting to the HIV-1/HIV-2 PLUS O EIA test. In addition, the segment had record installations of QCNet<SUP>&#8482;</SUP> software, which allows customers to connect to Bio-Rad via the Internet for their QC data processing needs. </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">Management will discuss these results in a conference call at 2 PM Pacific Time (5 PM Eastern Time) May 3, 2007. Interested parties can access the call by dialing 800-295-4740 (in the US), or 617-614-3925 (international), access number 87033646. The live webcast can be accessed at <U>http://www.bio-rad.com</U>. A replay of the call will be available at 888-286-8010 (in the US), or 617-801-6888 (international), access number 53777366, for seven days following the call and the webcast can be accessed at</P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">http://www.bio-rad.com for 30 days.</P>
<P style="margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:Arial"><B>About Bio-Rad</B></P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), has remained at the center of scientific discovery for more than 50 years manufacturing and distributing a broad range of products for the life science research and clinical diagnostics markets. The Company is renowned worldwide among hospitals, universities, major research institutions as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The Company employs over 5,000 people globally and had revenues of nearly $1.3 billion in 2006. For more information, visit www.bio-rad.com. </P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-family:Arial">Various statements made within this press release may constitute &#147;forward-looking statements&#148; for the purposes of the Securities and Exchange Commission&#146;s &#147;safe harbor&#148; provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. &nbsp;The forward-looking statements contained herein involve risks and uncertainties that could cause results to differ materially from the Company&#146;s expectation.</P>
<P style="margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">For more information contact:</P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">Christine Tsingos, Vice President and Chief Financial Officer, or</P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">Ron Hutton, Treasurer</P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">Bio-Rad Laboratories, Inc.</P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">510-724-7000</P>
<P style="line-height:21.333px; margin:0px; font-family:Arial">investor_relations@bio-rad.com</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><BR>
<BR>
<BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=378.8></TD><TD width=12></TD><TD width=84></TD><TD width=12></TD><TD width=84></TD></TR>
<TR><TD width=570.8 colspan=5><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD width=570.8 colspan=5><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>Condensed Consolidated Statements of Income </P>
</TD></TR>
<TR><TD width=570.8 colspan=5><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>(In thousands except per share data)</P>
</TD></TR>
<TR><TD width=570.8 colspan=5><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD width=378.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=180 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=378.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=180 colspan=3><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>Three Months Ended</P>
</TD></TR>
<TR><TD width=378.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=180 colspan=3><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>March 31,</P>
</TD></TR>
<TR><TD width=378.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>2007</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>2006</P>
</TD></TR>
<TR><TD width=378.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Net sales</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;322,508&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;308,338&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Cost of good sold</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>143,127&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>132,810&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Gross profit</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>179,381&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>175,528&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom width=378.8><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=84><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=84><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=bottom width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Selling, general and administrative expense</P>
</TD><TD valign=bottom width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>107,750&nbsp;</P>
</TD><TD valign=bottom width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>100,070&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Product research and development expense</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>32,781&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>28,091&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Interest expense</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>7,869&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>8,019&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Foreign exchange (gains) losses, net</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(272)</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>11&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Other (income) expense, net</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(6,186)</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(4,542)</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Income from continuing operations before taxes</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>37,439&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>43,879&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Provision for income taxes</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>10,442&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>12,681&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Net income</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;26,997&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31,198&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Basic earnings per share:</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Net income</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.02&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.19&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Weighted average common shares</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>26,580&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>26,277&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Diluted earnings per share:</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Net income</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.99&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.16&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Weighted average common shares</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>27,156&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=84><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>26,829&nbsp;</P>
</TD></TR>
<TR><TD width=378.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=378.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=84><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=381.733></TD><TD width=79></TD><TD width=15.733></TD><TD width=94.733></TD></TR>
<TR><TD valign=top width=571.2 colspan=4><P style="margin:0px; font-family:Arial" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=571.2 colspan=4><P style="margin:0px; font-family:Arial; font-size:12px" align=center>Condensed Consolidated Balance Sheets</P>
</TD></TR>
<TR><TD valign=top width=571.2 colspan=4><P style="margin:0px; font-family:Arial; font-size:12px" align=center>(In thousands)</P>
</TD></TR>
<TR><TD valign=top width=571.2 colspan=4><P style="margin:0px; font-family:Arial; font-size:12px" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=189.467 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=189.467 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="margin:0px; font-family:Arial; font-size:12px" align=right>March 31,&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=94.733><P style="margin:0px; font-family:Arial; font-size:12px" align=right>December 31,&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=79><P style="margin:0px; font-family:Arial; font-size:12px" align=right>2007&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=94.733><P style="margin:0px; font-family:Arial; font-size:12px" align=right>2006&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=94.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px">Current Assets:</P>
</TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Cash and cash equivalents </P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;230,314&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;223,607&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Short-term investments</P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>241,418&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>264,473&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Accounts receivable, net </P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>290,116&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>292,970&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Inventories, net </P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>259,965&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>253,045&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Other current assets</P>
</TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>107,879&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>95,682&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:28.8px; font-family:Arial; font-size:12px">Total current assets </P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>1,129,692&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>1,129,777&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px">Net property, plant and equipment </P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>188,763&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>189,627&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px">Goodwill </P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>119,492&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>119,492&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px">Purchased intangibles, net</P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>44,220&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>44,605&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px">Other assets </P>
</TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>124,876&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>112,667&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:28.8px; font-family:Arial; font-size:12px">Total assets</P>
</TD><TD style="border-bottom:2.667px double #000000" width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;1,607,043&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>&nbsp;&nbsp;&nbsp;&nbsp;$ &nbsp;&nbsp;&nbsp;&nbsp;1,596,168&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px">Current liabilities:</P>
</TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Notes payable and current maturities of long-term debt</P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,609&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,042&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Accounts payable</P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>61,946&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>83,411&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Accrued payroll and employee benefits</P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>70,590&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>92,101&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Sales, income and other taxes payable</P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>22,240&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>19,949&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Other current liabilities</P>
</TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>112,706&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>121,030&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:28.8px; font-family:Arial; font-size:12px">Total current liabilities</P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>272,091&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>319,533&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px">Long-term debt, net of current maturities</P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>425,504&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>425,625&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px">Other long-term liabilities</P>
</TD><TD width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>48,784&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>31,472&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px">Stockholders&#146; equity</P>
</TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>860,664&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>819,538&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="line-height:13.333px; margin:0px; text-indent:28.8px; font-family:Arial; font-size:12px">Total liabilities and stockholders&#146; equity </P>
</TD><TD style="border-bottom:2.667px double #000000" width=79><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;1,607,043&nbsp;</P>
</TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=94.733><P style="line-height:13.333px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;1,596,168&nbsp;</P>
</TD></TR>
<TR><TD width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=94.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=406.467></TD><TD width=99.6></TD><TD width=15.667></TD><TD width=1.733></TD><TD width=97.933></TD></TR>
<TR><TD valign=top width=621.4 colspan=5><P style="margin:0px; font-family:Arial" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=621.4 colspan=5><P style="margin:0px; font-family:Arial" align=center>Condensed Consolidated Statements of Cash Flows</P>
</TD></TR>
<TR><TD valign=top width=621.4 colspan=5><P style="margin:0px; font-family:Arial" align=center>(in thousands)</P>
</TD></TR>
<TR><TD valign=top width=621.4 colspan=5><P style="margin:0px; font-family:Arial" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=17.4 colspan=2><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=97.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=214.933 colspan=4><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>Three Months Ended</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=214.933 colspan=4><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>March 31,</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=99.6><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>2007&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>2006&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Cash flows from operating activities:</P>
</TD><TD valign=top width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Cash received from customers</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;327,214&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;299,764&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Cash paid to suppliers and employees</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(324,067)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(283,973)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Interest paid</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(8.540)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(8,938)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Income tax payments</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(12,424)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(9,562)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Litigation settlement </P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(1,033)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(44,167)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Other operating activities</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>6,209&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>4,805&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Net cash used in operating activities</P>
</TD><TD style="border-top:1px solid #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(12,641)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(42,071)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Cash flows from investing activities:</P>
</TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Capital expenditures, net</P>
</TD><TD width=99.6><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(10,636)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(11,318)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Receipt of restricted cash</P>
</TD><TD width=99.6><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>36,498&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Other investing activities</P>
</TD><TD width=99.6><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>22,494&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(16,943)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Net cash provided by investing activities</P>
</TD><TD style="border-top:1px solid #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>11,858&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=99.667 colspan=2><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>8,237&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Cash flows from financing activities:</P>
</TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Payments on long-term debt</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(123)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(117)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Other financing activities</P>
</TD><TD style="border-bottom:1px solid #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>7,388&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>2,813&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Net cash provided by financing activities</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>7,265&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>2,696&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Effect of exchange rate changes on cash </P>
</TD><TD style="border-bottom:1px solid #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>225&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>9&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Net (decrease) increase in cash and cash equivalents</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>6,707&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(31,129)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Cash and cash equivalents at beginning of period</P>
</TD><TD style="border-bottom:1px solid #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>223,607&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>296,716&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Cash and cash equivalents at end of period</P>
</TD><TD style="border-bottom:2.667px double #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;230,314&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;265,587&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Reconciliation of net income to net cash provided by operating activities:</P>
</TD><TD valign=top width=99.6><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>&nbsp;&nbsp;</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Net Income</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26,997&nbsp;</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31,198&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Adjustments to reconcile net income to net cash provided by</P>
</TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">operating activities (net of effects of acquisitions):</P>
</TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Depreciation and amortization</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>14,375&nbsp;</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>12,971&nbsp;</P>
</TD></TR>
<TR><TD width=406.467><P style="line-height:12px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Changes in working capital </P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(51,999)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(53,198)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Litigation settlement </P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(1,033)</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(44,167)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Other</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(981)</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>11,125&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Net cash used in operating activities</P>
</TD><TD style="border-bottom:2.667px double #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12,641)</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(42,071)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
